Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Revolutionary Cancer Support Nonprofit CanSup Emerges from Stealth to Launch $10M Campaign, Empowering Families Facing Cancer Nationwide

CanSup has officially launched with a bold $10M campaign to bring free, AI-powered cancer support to families nationwide. Founded by biotech leader David Haselwood, CanSup is transforming how patients navigate a diagnosis; offering personalized treatment insights, clinical trial access, and real guidance when it matters most. This is Cancer Support 2.0. Read the full release here.

News provided by

CanSup

May 01, 2025, 08:47 ET

Share this article

Share toX

Share this article

Share toX

Where understanding leads to better options — and better outcomes.

AUSTIN, Texas, May 1, 2025 /PRNewswire/ -- After operating quietly to build a groundbreaking cancer support platform, CanSup today announced its emergence from stealth and the launch of a $10 million capital campaign. Founded by biotech leader David Haselwood, the 501(c)(3) nonprofit is now scaling its life-changing services for families facing cancer.

Continue Reading
Co-founder of CanSup, biotech leader, and longtime advocate for patients and families. David Haselwood is leading the charge to transform cancer care through AI-powered, patient-centered support, making clarity, access, and hope possible for thousands nationwide.
Co-founder of CanSup, biotech leader, and longtime advocate for patients and families. David Haselwood is leading the charge to transform cancer care through AI-powered, patient-centered support, making clarity, access, and hope possible for thousands nationwide.

Built on the belief that every patient deserves access to the best possible treatment options, CanSup is revolutionizing cancer support through AI-driven, patient-centered guidance. The nonprofit harnesses cutting-edge artificial intelligence, deep clinical expertise, and a commitment to health equity to break down the barriers that prevent too many families from accessing life-saving care.

"When you or a loved one is diagnosed with cancer, finding the right treatment can be overwhelming, confusing, and deeply isolating," said David Haselwood, Founder and Executive Director of CanSup. "We are here to change that. With the power of AI combined with over three decades of experience helping cancer patients, CanSup is giving patients the clarity, resources, and hope they need to fight back — and to survive."

The newly announced $10 million campaign will directly fund the expansion of CanSup's services, allowing the organization to reach thousands of additional families in need. Contributions will support advancements in clinical guidance technology, patient navigation services, and outreach initiatives that prioritize underserved communities.

Founded in 2023, CanSup has already demonstrated its transformative potential during its stealth development phase. Now, the organization is ready to scale nationwide, offering free, personalized support to every patient and family when they need it most.

CanSup is Cancer Support 2.0

For too long, cancer support has meant pamphlets, fragmented advice, and overwhelming choices with little real guidance. CanSup is changing that.

Blending the power of advanced AI with deep clinical expertise, CanSup offers families a smarter, faster, and more personalized way to navigate a diagnosis. Patients and caregivers receive customized support that connects them to cutting-edge treatments, clinical trials, second opinions, and vital resources — all tailored to their specific situation.

At the heart of CanSup's model is a simple but critical truth: understanding unlocks better options, and better options create better outcomes. By helping families truly understand their diagnosis, treatment landscape, and available opportunities, CanSup empowers them to make decisions that can profoundly change the course of their lives.

Unlike traditional patient advocacy, CanSup delivers real-time, AI-enhanced clinically-backed insights combined with decades of frontline experience navigating clinical trials, FDA approvals, and real-world patient outcomes. This next-generation approach doesn't just offer emotional support — it delivers actionable pathways to survival and hope. 

CanSup is completely unbiased and focused solely on the patient and their family, relentlessly pursuing the best information, insights and options for the patients it serves.  By prioritizing clarity, access, and equity, CanSup is breaking the old model wide open — and building a future where every patient has a real fighting chance.

How CanSup is Different

  • Smarter Tools, Not Just Support: Traditional nurse navigators and advocacy groups often provide emotional support and local referrals. CanSup goes further - offering families nationwide access to clinical trials, second opinions, and treatment options through AI-enhanced, patient-specific guidance.

  • Unbiased and Patient-Centered: CanSup is not tied to any hospital system, insurer, or provider network. Our only allegiance is to the patient, ensuring the very best opportunities are surfaced no matter where they are.

  • Free Access For Every Family: Whether patients are newly diagnosed, exploring trials, or facing complex decisions, CanSup provides support at no cost, removing financial barriers from the very first conversation.

Families who have worked with CanSup during its development phase have called the platform "life-changing," giving them clarity, confidence, and hope when they needed it most. Learn more at www.cansup.org/testimonials.

Call to Action: Join the CanSup Mission

CanSup is launching a $10 million national capital campaign to expand its life-changing services to more families across the country. Every donation directly supports patients and caregivers who need help navigating their cancer journey.

Just one contribution can change everything for a family navigating the hardest time of their lives.

  •  $5,000 – Fully supports one family through their entire cancer journey, ensuring they have access to specialists, treatment insights, clinical trial matching, and the knowledge they need to make the best decisions.

Thousands of families are facing this battle today. They shouldn't have to face it alone.

CanSup is calling on individuals, families, and philanthropic partners to help rewrite what's possible in cancer care. With your support, we can ensure that more patients don't just hear a diagnosis — they receive the clarity, options, and opportunities they need to fight back.  Learn more or make a tax-deductible donation by visiting www.cansup.org.

About CanSup
CanSup is a 501(c)(3) nonprofit organization dedicated to revolutionizing cancer support through AI-driven, patient-centered guidance. Founded by David Haselwood, a biotech entrepreneur with 30+ years of experience in clinical trials, FDA approvals, and life sciences innovation, CanSup is breaking down the barriers that prevent patients from accessing life-saving treatments.

Through advanced AI, deep clinical intelligence, and a commitment to equitable cancer care, CanSup is ensuring that thousands of families nationwide have the knowledge, resources, and treatment opportunities they deserve.

Media Contact:
Rachel Goodlad
[email protected] | 832-704-2848

SOURCE CanSup

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.